214 related articles for article (PubMed ID: 16487009)
21. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
[TBL] [Abstract][Full Text] [Related]
22. Involvement of PTEN promoter methylation in cerebral cavernous malformations.
Zhu Y; Wloch A; Wu Q; Peters C; Pagenstecher A; Bertalanffy H; Sure U
Stroke; 2009 Mar; 40(3):820-6. PubMed ID: 19118244
[TBL] [Abstract][Full Text] [Related]
23. Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis.
Aldred MA; Ginn-Pease ME; Morrison CD; Popkie AP; Gimm O; Hoang-Vu C; Krause U; Dralle H; Jhiang SM; Plass C; Eng C
Cancer Res; 2003 Jun; 63(11):2864-71. PubMed ID: 12782592
[TBL] [Abstract][Full Text] [Related]
24. Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways.
Yeh JJ; Marsh DJ; Zedenius J; Dwight T; Delbridge L; Robinson BG; Eng C
Genes Chromosomes Cancer; 1999 Dec; 26(4):322-8. PubMed ID: 10534767
[TBL] [Abstract][Full Text] [Related]
25. High frequency of loss of heterozygosity in imprinted, compared with nonimprinted, genomic regions in follicular thyroid carcinomas and atypical adenomas.
Sarquis MS; Weber F; Shen L; Broelsch CE; Jhiang SM; Zedenius J; Frilling A; Eng C
J Clin Endocrinol Metab; 2006 Jan; 91(1):262-9. PubMed ID: 16249278
[TBL] [Abstract][Full Text] [Related]
26. Lack of mutations in the thyroid hormone receptor (TR) alpha and beta genes but frequent hypermethylation of the TRbeta gene in differentiated thyroid tumors.
Joseph B; Ji M; Liu D; Hou P; Xing M
J Clin Endocrinol Metab; 2007 Dec; 92(12):4766-70. PubMed ID: 17911173
[TBL] [Abstract][Full Text] [Related]
27. BRAF and endocrine tumors: mutations are frequent in papillary thyroid carcinomas, rare in endocrine tumors of the gastrointestinal tract and not detected in other endocrine tumors.
Perren A; Schmid S; Locher T; Saremaslani P; Bonvin C; Heitz PU; Komminoth P
Endocr Relat Cancer; 2004 Dec; 11(4):855-60. PubMed ID: 15613458
[TBL] [Abstract][Full Text] [Related]
28. [Relationship of methylation of promoter and expression of PTEN gene in papillary thyroid carcinoma].
Yin DT; Yin FY; Zheng LY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Apr; 45(4):330-3. PubMed ID: 20627056
[No Abstract] [Full Text] [Related]
29. PTEN lipid phosphatase activity and proper subcellular localization are necessary and sufficient for down-regulating AKT phosphorylation in the nucleus in Cowden syndrome.
He X; Saji M; Radhakrishnan D; Romigh T; Ngeow J; Yu Q; Wang Y; Ringel MD; Eng C
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2179-87. PubMed ID: 22962422
[TBL] [Abstract][Full Text] [Related]
30. Expression of nicotinamide adenine dinucleotide phosphate oxidase flavoprotein DUOX genes and proteins in human papillary and follicular thyroid carcinomas.
Lacroix L; Nocera M; Mian C; Caillou B; Virion A; Dupuy C; Filetti S; Bidart JM; Schlumberger M
Thyroid; 2001 Nov; 11(11):1017-23. PubMed ID: 11762710
[TBL] [Abstract][Full Text] [Related]
31. Association of sporadic breast cancer with PTEN/MMAC1/TEP1 promoter hypermethylation.
Sadeq V; Isar N; Manoochehr T
Med Oncol; 2011 Jun; 28(2):420-3. PubMed ID: 20237868
[TBL] [Abstract][Full Text] [Related]
32. TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Wang N; Liu T; Sofiadis A; Juhlin CC; Zedenius J; Höög A; Larsson C; Xu D
Cancer; 2014 Oct; 120(19):2965-79. PubMed ID: 24898513
[TBL] [Abstract][Full Text] [Related]
33. DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.
Mancikova V; Buj R; Castelblanco E; Inglada-Pérez L; Diez A; de Cubas AA; Curras-Freixes M; Maravall FX; Mauricio D; Matias-Guiu X; Puig-Domingo M; Capel I; Bella MR; Lerma E; Castella E; Reverter JL; Peinado MÁ; Jorda M; Robledo M
Int J Cancer; 2014 Aug; 135(3):598-610. PubMed ID: 24382797
[TBL] [Abstract][Full Text] [Related]
34. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity.
Laury AR; Bongiovanni M; Tille JC; Kozakewich H; Nosé V
Thyroid; 2011 Feb; 21(2):135-44. PubMed ID: 21190448
[TBL] [Abstract][Full Text] [Related]
35. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K
Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930
[TBL] [Abstract][Full Text] [Related]
36. HLA class II expression in well differentiated thyroid carcinoma: correlation with clinicopathological features.
Knoll MR; Schwab M; Oestreich K; Rumstadt B; Hagmüller E
J Exp Clin Cancer Res; 1997 Jun; 16(2):177-82. PubMed ID: 9261744
[TBL] [Abstract][Full Text] [Related]
37. Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis.
Yeager N; Klein-Szanto A; Kimura S; Di Cristofano A
Cancer Res; 2007 Feb; 67(3):959-66. PubMed ID: 17283127
[TBL] [Abstract][Full Text] [Related]
38. Ras oncogene mutations in thyroid tumors: polymerase chain reaction-restriction-fragment-length polymorphism analysis from paraffin-embedded tissues.
Capella G; Matias-Guiu X; Ampudia X; de Leiva A; Perucho M; Prat J
Diagn Mol Pathol; 1996 Mar; 5(1):45-52. PubMed ID: 8919545
[TBL] [Abstract][Full Text] [Related]
39. PTEN promoter is methylated in a proportion of invasive breast cancers.
Khan S; Kumagai T; Vora J; Bose N; Sehgal I; Koeffler PH; Bose S
Int J Cancer; 2004 Nov; 112(3):407-10. PubMed ID: 15382065
[TBL] [Abstract][Full Text] [Related]
40. Aberrant deoxyribonucleic acid methylation in human thyroid tumors.
Matsuo K; Tang SH; Zeki K; Gutman RA; Fagin JA
J Clin Endocrinol Metab; 1993 Oct; 77(4):991-5. PubMed ID: 7691865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
